Cargando…

The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients

BACKGROUND: Cancer has always been a serious health threat for human. Patients with cancer are at high risk of drug-related problems (DRPs) due to multi-morbidity associated polypharmacy. However, data is lacking in identifying and addressing potential DRPs in cancer patients in China. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jianping, Xu, Rong, Zhao, Xincai, Wang, Yonggang, Zhu, Wanhu, Xiao, Misu, Hu, Haiyan, Tang, Lina, Shen, Zan, Guo, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797392/
https://www.ncbi.nlm.nih.gov/pubmed/35116495
http://dx.doi.org/10.21037/tcr-20-3164
_version_ 1784641541567938560
author Zhang, Jianping
Xu, Rong
Zhao, Xincai
Wang, Yonggang
Zhu, Wanhu
Xiao, Misu
Hu, Haiyan
Tang, Lina
Shen, Zan
Guo, Cheng
author_facet Zhang, Jianping
Xu, Rong
Zhao, Xincai
Wang, Yonggang
Zhu, Wanhu
Xiao, Misu
Hu, Haiyan
Tang, Lina
Shen, Zan
Guo, Cheng
author_sort Zhang, Jianping
collection PubMed
description BACKGROUND: Cancer has always been a serious health threat for human. Patients with cancer are at high risk of drug-related problems (DRPs) due to multi-morbidity associated polypharmacy. However, data is lacking in identifying and addressing potential DRPs in cancer patients in China. This study aims to investigate the prevalence of DRPs and evaluate the effectiveness of an independent anti-neoplastic medication therapy management (MTM) system in ambulatory cancer patients. METHODS: This is a retrospective study. An independent anti-neoplastic MTM system in Shanghai Jiao Tong University affiliated sixth People's Hospital was established in 2018 with the collaboration of oncologists, clinical pharmacists and software engineers. The system contains an independent clinic of pharmacy and MTM software. The software consisted of six modules to help clinical pharmacists serve the tumor patients. The six modules include medication therapy review, intervention plan, personal medication record, medication-related action plan, intervention and/or referral, and documentation and follow-up. RESULTS: A total of 173 eligible tumor patients visited the anti-neoplastic pharmaceutical clinic and were recorded in the independent anti-neoplastic MTM system from Jun 2018 to May 2019. The average clinic visits were 2.4 times of the study participants. Two thirds patients (117/173) had one or more identified DRPs in medication therapy review. Adverse drug reaction, potential drug interaction and non-adherence were the leading DRPs. 85.8% of DRPs could be resolved (cured or improved) in four weeks. Tumor patients showed medication adherence reached 84–100% after three or four times of follow-up and intervention. CONCLUSIONS: The participation of clinical pharmacists in managing polypharmacy tumor patients, with the independent anti-neoplastic MTM system, facilitated the identifying and solving DRPs, especially improving medication adherence of patients, and thus enhancing the effectiveness, safety and rational use of medication.
format Online
Article
Text
id pubmed-8797392
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87973922022-02-02 The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients Zhang, Jianping Xu, Rong Zhao, Xincai Wang, Yonggang Zhu, Wanhu Xiao, Misu Hu, Haiyan Tang, Lina Shen, Zan Guo, Cheng Transl Cancer Res Original Article BACKGROUND: Cancer has always been a serious health threat for human. Patients with cancer are at high risk of drug-related problems (DRPs) due to multi-morbidity associated polypharmacy. However, data is lacking in identifying and addressing potential DRPs in cancer patients in China. This study aims to investigate the prevalence of DRPs and evaluate the effectiveness of an independent anti-neoplastic medication therapy management (MTM) system in ambulatory cancer patients. METHODS: This is a retrospective study. An independent anti-neoplastic MTM system in Shanghai Jiao Tong University affiliated sixth People's Hospital was established in 2018 with the collaboration of oncologists, clinical pharmacists and software engineers. The system contains an independent clinic of pharmacy and MTM software. The software consisted of six modules to help clinical pharmacists serve the tumor patients. The six modules include medication therapy review, intervention plan, personal medication record, medication-related action plan, intervention and/or referral, and documentation and follow-up. RESULTS: A total of 173 eligible tumor patients visited the anti-neoplastic pharmaceutical clinic and were recorded in the independent anti-neoplastic MTM system from Jun 2018 to May 2019. The average clinic visits were 2.4 times of the study participants. Two thirds patients (117/173) had one or more identified DRPs in medication therapy review. Adverse drug reaction, potential drug interaction and non-adherence were the leading DRPs. 85.8% of DRPs could be resolved (cured or improved) in four weeks. Tumor patients showed medication adherence reached 84–100% after three or four times of follow-up and intervention. CONCLUSIONS: The participation of clinical pharmacists in managing polypharmacy tumor patients, with the independent anti-neoplastic MTM system, facilitated the identifying and solving DRPs, especially improving medication adherence of patients, and thus enhancing the effectiveness, safety and rational use of medication. AME Publishing Company 2021-04 /pmc/articles/PMC8797392/ /pubmed/35116495 http://dx.doi.org/10.21037/tcr-20-3164 Text en 2021 Translational Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Original Article
Zhang, Jianping
Xu, Rong
Zhao, Xincai
Wang, Yonggang
Zhu, Wanhu
Xiao, Misu
Hu, Haiyan
Tang, Lina
Shen, Zan
Guo, Cheng
The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients
title The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients
title_full The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients
title_fullStr The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients
title_full_unstemmed The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients
title_short The effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients
title_sort effectiveness of an independent anti-neoplastic medication therapy management system in ambulatory cancer patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797392/
https://www.ncbi.nlm.nih.gov/pubmed/35116495
http://dx.doi.org/10.21037/tcr-20-3164
work_keys_str_mv AT zhangjianping theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT xurong theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT zhaoxincai theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT wangyonggang theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT zhuwanhu theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT xiaomisu theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT huhaiyan theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT tanglina theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT shenzan theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT guocheng theeffectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT zhangjianping effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT xurong effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT zhaoxincai effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT wangyonggang effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT zhuwanhu effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT xiaomisu effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT huhaiyan effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT tanglina effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT shenzan effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients
AT guocheng effectivenessofanindependentantineoplasticmedicationtherapymanagementsysteminambulatorycancerpatients